GB8514090D0
(en)
*
|
1985-06-04 |
1985-07-10 |
Sandoz Ltd |
Organic compounds
|
JPS60100516A
(ja)
*
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
EP0190833B1
(de)
*
|
1985-02-07 |
1991-03-27 |
Takeda Chemical Industries, Ltd. |
Verfahren zur Herstellung von Mikrokapseln
|
JP2551756B2
(ja)
*
|
1985-05-07 |
1996-11-06 |
武田薬品工業株式会社 |
ポリオキシカルボン酸エステルおよびその製造法
|
US4734399A
(en)
*
|
1985-08-06 |
1988-03-29 |
Hoffmann-La Roche Inc. |
Growth hormone releasing factor analogs
|
US5112619A
(en)
*
|
1985-11-12 |
1992-05-12 |
Eli Lilly And Company |
Orally administerable sustained release pharmaceutical formulation
|
DE3682257D1
(de)
*
|
1985-11-22 |
1991-12-05 |
Takeda Chemical Industries Ltd |
Liposomzusammensetzung.
|
CA1275922C
(en)
*
|
1985-11-28 |
1990-11-06 |
Harunobu Amagase |
Treatment of cancer
|
US4780320A
(en)
*
|
1986-04-29 |
1988-10-25 |
Pharmetrix Corp. |
Controlled release drug delivery system for the periodontal pocket
|
US4832686A
(en)
*
|
1986-06-24 |
1989-05-23 |
Anderson Mark E |
Method for administering interleukin-2
|
JPS6341416A
(ja)
*
|
1986-08-08 |
1988-02-22 |
Takeda Chem Ind Ltd |
鎮痛性ペプチド含有マイクロカプセルの製造法
|
JP2526589B2
(ja)
*
|
1986-08-08 |
1996-08-21 |
武田薬品工業株式会社 |
ペプチド含有マイクロカプセルおよびその製造法
|
JPH0725689B2
(ja)
*
|
1986-10-07 |
1995-03-22 |
中外製薬株式会社 |
顆粒球コロニ−刺激因子を含有する徐放性製剤
|
CA1321048C
(en)
*
|
1987-03-05 |
1993-08-10 |
Robert W. J. Lencki |
Microspheres and method of producing same
|
US4857335A
(en)
*
|
1987-03-27 |
1989-08-15 |
Lim Technology Laboratories, Inc. |
Liquid controlled release formulations and method of producing same via multiple emulsion process
|
US5143661A
(en)
*
|
1987-05-26 |
1992-09-01 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules
|
US5500228A
(en)
*
|
1987-05-26 |
1996-03-19 |
American Cyanamid Company |
Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease
|
US4880632A
(en)
*
|
1987-09-08 |
1989-11-14 |
The United States Of America |
Prevention of fescue toxicosis
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
JPH0725649B2
(ja)
*
|
1987-10-12 |
1995-03-22 |
而至歯科工業株式会社 |
消毒剤含有アルギン酸印象材
|
US5187150A
(en)
*
|
1987-10-14 |
1993-02-16 |
Debiopharm S.A. |
Polyester-based composition for the controlled release of polypeptide medicinal substances
|
AU2810189A
(en)
*
|
1987-10-30 |
1989-05-23 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
US5051261A
(en)
*
|
1987-11-24 |
1991-09-24 |
Fmc Corporation |
Method for preparing a solid sustained release form of a functionally active composition
|
US5290562A
(en)
*
|
1987-11-27 |
1994-03-01 |
L V M H Recherche |
Compositions and methods employing liposomes including tyrosine or a tyrosine derivative
|
US5236704A
(en)
*
|
1988-01-28 |
1993-08-17 |
Sumitomo Pharmaceuticals Co., Ltd. |
Controlled release formulation
|
JP2670680B2
(ja)
*
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
US4952408A
(en)
*
|
1988-05-23 |
1990-08-28 |
Georgetown University |
Liposome-encapsulated vinca alkaloids and their use in combatting tumors
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
US5298255A
(en)
*
|
1988-10-28 |
1994-03-29 |
Terumo Kabushiki Kaisha |
Antithrombic medical material, artificial internal organ, and method for production of antithrombic medical material
|
US5236355A
(en)
*
|
1988-12-22 |
1993-08-17 |
American Cyanamid Company |
Apparatus for the treatment of periodontal disease
|
DE68915132T2
(de)
*
|
1988-12-22 |
1994-12-08 |
American Cyanamid Co |
Verfahren zur Behandlung von Periodontitis durch protrahierte Wirkstoffabgabe von Arzneimitteln in der Zahnhöhle, Zusammensetzung davon und Vorrichtung zur Verabreichung.
|
US5051305A
(en)
*
|
1988-12-30 |
1991-09-24 |
Arcade, Inc. |
Stabilized perfume-containing microcapsules and method of preparing the same
|
DE69024953T3
(de)
*
|
1989-05-04 |
2005-01-27 |
Southern Research Institute, Birmingham |
Einkapselungsverfahren
|
IT8920486A0
(it)
*
|
1989-05-12 |
1989-05-12 |
Isf Spa |
Composizioni farmaceutiche.
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
PH30995A
(en)
*
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
JP2571874B2
(ja)
*
|
1989-11-06 |
1997-01-16 |
アルカーメス コントロールド セラピューティクス,インコーポレイテッド |
タンパク質マイクロスフェア組成物
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5198220A
(en)
*
|
1989-11-17 |
1993-03-30 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
JP2958103B2
(ja)
*
|
1989-12-12 |
1999-10-06 |
エーザイ株式会社 |
プラズマ照射固形製剤
|
MY107937A
(en)
*
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
JP2653255B2
(ja)
|
1990-02-13 |
1997-09-17 |
武田薬品工業株式会社 |
長期徐放型マイクロカプセル
|
US5478564A
(en)
*
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
DE69129770T2
(de)
*
|
1990-04-13 |
1998-11-19 |
Takeda Chemical Industries Ltd |
Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung
|
DK0528978T3
(da)
*
|
1990-05-16 |
2003-02-17 |
Southern Res Inst |
Mikrokapsler til reguleret afgivelse og deres anvendelse i stimulering af nervefibervækst
|
US6517859B1
(en)
|
1990-05-16 |
2003-02-11 |
Southern Research Institute |
Microcapsules for administration of neuroactive agents
|
JP3116311B2
(ja)
*
|
1990-06-13 |
2000-12-11 |
エーザイ株式会社 |
マイクロスフィアの製法
|
US5364839A
(en)
*
|
1990-06-18 |
1994-11-15 |
Genetics Institute, Inc. |
Osteoinductive pharmaceutical formulations
|
GB9016885D0
(en)
*
|
1990-08-01 |
1990-09-12 |
Scras |
Sustained release pharmaceutical compositions
|
US5418010A
(en)
*
|
1990-10-05 |
1995-05-23 |
Griffith Laboratories Worldwide, Inc. |
Microencapsulation process
|
KR930006431B1
(ko)
*
|
1990-10-11 |
1993-07-16 |
재단법인 한국화학연구소 |
약물의 미세캡슐화 방법
|
NO302481B1
(no)
*
|
1990-10-16 |
1998-03-09 |
Takeda Chemical Industries Ltd |
Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
|
US5206023A
(en)
*
|
1991-01-31 |
1993-04-27 |
Robert F. Shaw |
Method and compositions for the treatment and repair of defects or lesions in cartilage
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5654009A
(en)
*
|
1991-03-25 |
1997-08-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Delayed action preparation
|
JPH04364131A
(ja)
*
|
1991-04-03 |
1992-12-16 |
Sanwa Kagaku Kenkyusho Co Ltd |
易吸収性モチリン製剤
|
ATE142460T1
(de)
*
|
1991-06-21 |
1996-09-15 |
Genetics Inst |
Osteogene proteine enthaltende arzneimittel
|
US5252337A
(en)
*
|
1991-06-25 |
1993-10-12 |
Eurand America, Inc. |
Controlled release calcium channel blocker microcapsules
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
US5270300A
(en)
*
|
1991-09-06 |
1993-12-14 |
Robert Francis Shaw |
Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
|
DE69220317T2
(de)
*
|
1991-10-01 |
1997-10-16 |
Takeda Chemical Industries Ltd |
Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
|
US5288502A
(en)
*
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
JPH07503943A
(ja)
*
|
1991-10-29 |
1995-04-27 |
クローバー コンソリデイテッド,リミテッド |
封入及び薬剤放出に有用な架橋性の多糖類、ポリカチオン及び脂質
|
ATE157864T1
(de)
*
|
1991-12-18 |
1997-09-15 |
Warner Lambert Co |
Verfahren für die herstellung einer festen dispersion
|
WO1993015722A1
(en)
*
|
1992-02-07 |
1993-08-19 |
Syntex (Usa) Inc. |
Controlled delivery of pharmaceuticals from preformed porous microparticles
|
US5912015A
(en)
*
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
WO1993019702A1
(en)
*
|
1992-04-06 |
1993-10-14 |
Uroplasty, Inc. |
Treatment of reflux disorder by microparticles injection
|
US5922652A
(en)
*
|
1992-05-05 |
1999-07-13 |
Procter & Gamble |
Microencapsulated oil field chemicals
|
US5716644A
(en)
*
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US20030035845A1
(en)
*
|
1992-06-11 |
2003-02-20 |
Zale Stephen E. |
Composition for sustained release of non-aggregated erythropoietin
|
US5674534A
(en)
*
|
1992-06-11 |
1997-10-07 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
JP2651320B2
(ja)
*
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
AU4198793A
(en)
*
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
DE69316101T2
(de)
*
|
1992-08-07 |
1998-10-22 |
Takeda Chemical Industries Ltd |
Herstellung von Mikrokapseln, die wasserlösliche Arzneimittel enthalten
|
JP3277342B2
(ja)
*
|
1992-09-02 |
2002-04-22 |
武田薬品工業株式会社 |
徐放性マイクロカプセルの製造法
|
US5700485A
(en)
*
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
PT659073E
(pt)
*
|
1992-09-10 |
2002-06-28 |
Childrens Medical Center |
Matrizes polimericas biodegradaveis para entrega sustentada de agentes anestesicos locais
|
DE4231493A1
(de)
*
|
1992-09-21 |
1994-03-24 |
Nordmark Arzneimittel Gmbh |
Verfahren zur Herstellung von Pellets aus einem Ephedrinderivat
|
EP0595030A3
(de)
*
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Mehrkern-Mikrosphären mit verzögerter Wirkstoffabgabe und Verfahren zu deren Herstellung.
|
US5242910A
(en)
*
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5310742A
(en)
*
|
1992-11-30 |
1994-05-10 |
Elias Alan N |
Uses for thioureylenes
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
JPH06239746A
(ja)
*
|
1993-02-12 |
1994-08-30 |
Mayumi Okada |
モルヒネ徐放性製剤
|
ATE197550T1
(de)
*
|
1993-02-23 |
2000-12-15 |
Genentech Inc |
Stabilisierung von mit organischen lösungsmittel behandelten polypeptiden mit einem hilfsstoff
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
ES2070076B1
(es)
*
|
1993-04-20 |
1996-04-16 |
Cusi Lab |
Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
|
US5449663A
(en)
*
|
1993-06-11 |
1995-09-12 |
Bicher; Haim I. |
Antineoplastic compositions
|
US5447725A
(en)
*
|
1993-06-11 |
1995-09-05 |
The Procter & Gamble Company |
Methods for aiding periodontal tissue regeneration
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
DE69432867T2
(de)
*
|
1993-11-18 |
2004-04-22 |
Sirtex Medical Ltd., Burswood |
Zubereitung mit gesteuerter freisetzung
|
US5474985A
(en)
*
|
1993-12-22 |
1995-12-12 |
The Regents Of The University Of California |
Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
|
DE69508985T2
(de)
*
|
1994-02-21 |
1999-08-19 |
Takeda Chemical Industries Ltd |
Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe
|
IE940292A1
(en)
*
|
1994-04-06 |
1995-10-18 |
Elan Corp Plc |
Biodegradable microcapsules and method for their manufacture
|
US5538733A
(en)
*
|
1994-07-07 |
1996-07-23 |
Willmar Poultry Company, Inc. |
Method of priming an immune response in a one-day old animal
|
CA2150060C
(en)
*
|
1994-07-08 |
2000-01-11 |
John T. Biggs |
Seamless multimedia conferencing system using enhanced endpoint devices
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5520923A
(en)
*
|
1994-09-19 |
1996-05-28 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
US5538737A
(en)
*
|
1994-11-30 |
1996-07-23 |
Applied Analytical Industries, Inc. |
Oral compositions of H2 -antagonists
|
DE4443175A1
(de)
*
|
1994-12-05 |
1996-06-13 |
Jenapharm Gmbh |
Neue pulsatile Arzneiform
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5879712A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
ATE267587T1
(de)
|
1995-06-09 |
2004-06-15 |
Euro Celtique Sa |
Formulierungen und verfahren für eine verlängerte lokalanästhesie
|
AU710347B2
(en)
*
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
TW448055B
(en)
*
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
EP0862419B2
(de)
|
1995-11-09 |
2010-11-17 |
Microbiological Research Authority |
Mikroverkapselte dna zur impfung und gentherapie
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
US5747060A
(en)
*
|
1996-03-26 |
1998-05-05 |
Euro-Celtique, S.A. |
Prolonged local anesthesia with colchicine
|
JPH11511763A
(ja)
|
1996-06-24 |
1999-10-12 |
ユーロ―セルティーク,エス.エイ. |
安全な局所麻酔の提供方法
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7435425B2
(en)
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
PT839525E
(pt)
|
1996-10-31 |
2004-10-29 |
Takeda Chemical Industries Ltd |
Preparacao de libertacao prolongada
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5945126A
(en)
*
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
AU751267B2
(en)
|
1997-06-30 |
2002-08-08 |
Monsanto Technology Llc |
Microparticles containing agricultural active ingredients
|
BR9815499A
(pt)
|
1997-07-02 |
2001-01-02 |
Euro Celtique Sa |
Anestesia prolongada nas juntas e nos espacos corporais.
|
US6391452B1
(en)
*
|
1997-07-18 |
2002-05-21 |
Bayer Corporation |
Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
EP1014946B1
(de)
|
1997-09-18 |
2010-04-07 |
Pacira Pharmaceuticals, Inc. |
Retardierte freisetzung liposmaler anesthetischer zusammensetzungen.
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6106875A
(en)
*
|
1997-10-08 |
2000-08-22 |
Givaudan Roure (International) Sa |
Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
|
US6045835A
(en)
*
|
1997-10-08 |
2000-04-04 |
Givaudan Roure (International) Sa |
Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
|
SE512663C2
(sv)
*
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
JP4234803B2
(ja)
|
1997-10-27 |
2009-03-04 |
久光製薬株式会社 |
薬物放出速度が制御された医薬組成物
|
TW577758B
(en)
|
1997-10-27 |
2004-03-01 |
Ssp Co Ltd |
Intra-articular preparation for the treatment of arthropathy
|
ES2384094T3
(es)
*
|
1997-11-14 |
2012-06-29 |
Pacira Pharmaceuticals, Inc. |
Producción de liposomas multivesiculares
|
CA2317039C
(en)
|
1998-01-21 |
2009-09-29 |
Takeda Chemical Industries, Ltd. |
Lyophilization method for sustained-release preparations
|
US20030180368A1
(en)
*
|
1998-03-14 |
2003-09-25 |
Cenes Drug Delivery Limited |
Production of microparticles
|
NZ506202A
(en)
|
1998-03-19 |
2003-10-31 |
Bristol Myers Squibb Co |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
US7128927B1
(en)
*
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
US6217844B1
(en)
|
1998-04-27 |
2001-04-17 |
Praecis Pharmaceuticals, Inc. |
Methods for detecting lesions in dense breast tissue using LHRH antagonists
|
US7022683B1
(en)
*
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
GB9810236D0
(en)
*
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6451335B1
(en)
|
1998-07-02 |
2002-09-17 |
Euro-Celtique S.A. |
Formulations and methods for providing prolonged local anesthesia
|
IL140899A0
(en)
|
1998-07-17 |
2002-02-10 |
Skyepharma Inc |
Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
|
US20070009605A1
(en)
*
|
1998-07-23 |
2007-01-11 |
Ignatious Francis X |
Encapsulation of water soluble peptides
|
US6200590B1
(en)
|
1998-08-10 |
2001-03-13 |
Naphcare, Inc. |
Controlled, phased-release suppository and its method of production
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
US6204308B1
(en)
|
1999-03-01 |
2001-03-20 |
Novartis Ag |
Organic compounds
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
US6709427B1
(en)
|
1999-08-05 |
2004-03-23 |
Kensey Nash Corporation |
Systems and methods for delivering agents into targeted tissue of a living being
|
WO2001010416A1
(en)
*
|
1999-08-11 |
2001-02-15 |
Alkermes Controlled Therapeutics, Inc. |
Method of delivering a chemotherapeutic agent to a solid tumor
|
CN100387228C
(zh)
*
|
1999-08-27 |
2008-05-14 |
布鲁克伍德药品公司 |
可注射的美沙酮、部分类鸦片激动剂或类鸦片拮抗剂微粒组合物及其用途
|
US7582311B1
(en)
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
DK1223990T3
(da)
|
1999-10-15 |
2004-11-29 |
Inst Genetics Llc |
Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
|
US7651703B2
(en)
*
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US6682754B2
(en)
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
US7771746B2
(en)
*
|
1999-12-03 |
2010-08-10 |
Polichem Sa |
Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
|
ES2169980B1
(es)
|
1999-12-17 |
2003-11-01 |
Lipotec Sa |
Microcapsulas para la liberacion prolongada de farmacos.
|
TWI284048B
(en)
|
2000-01-27 |
2007-07-21 |
Zentaris Ag |
Compressed microparticles for dry injection
|
WO2001055217A1
(en)
*
|
2000-01-27 |
2001-08-02 |
Medimmune, Inc. |
Ultra high affinity neutralizing antibodies
|
US6465425B1
(en)
*
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
JP2003525061A
(ja)
|
2000-03-01 |
2003-08-26 |
メディミューン,インコーポレイテッド |
高効力組換え抗体およびその産生法
|
US7153525B1
(en)
|
2000-03-22 |
2006-12-26 |
The University Of Kentucky Research Foundation |
Microemulsions as precursors to solid nanoparticles
|
ATE488233T1
(de)
*
|
2000-04-26 |
2010-12-15 |
Watson Pharmaceuticals Inc |
Verminderung der nebenwirkungen bei der oxybutynin-therapie
|
US7029694B2
(en)
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
AR023940A1
(es)
|
2000-05-03 |
2002-09-04 |
Eriochem Sa |
Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
CN1141974C
(zh)
*
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
EP1297850B1
(de)
|
2000-07-05 |
2015-08-19 |
Takeda Pharmaceutical Company Limited |
Medizinische zusammensetzungen zur behandlung von mit sexualhormonen verbundenen erkrankungen
|
DE60118575T3
(de)
*
|
2000-08-07 |
2011-05-19 |
Takeda Pharmaceutical Co. Ltd. |
Milchsäurepolymer und verfahren zu dessen herstellung
|
FR2814380B1
(fr)
*
|
2000-09-25 |
2002-11-08 |
Serobiologiques Lab Sa |
Poudre de microcapsules et procede d'obtention
|
US7374782B2
(en)
|
2000-10-27 |
2008-05-20 |
Baxter International Inc. |
Production of microspheres
|
US8470359B2
(en)
|
2000-11-13 |
2013-06-25 |
Qlt Usa, Inc. |
Sustained release polymer
|
US7179900B2
(en)
*
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
DE60128261T3
(de)
|
2000-12-21 |
2016-06-30 |
Alrise Biosystems Gmbh |
Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
|
US20030152637A1
(en)
*
|
2001-01-25 |
2003-08-14 |
Mark Chasin |
Local anesthetic, and method of use
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
FR2822834B1
(fr)
*
|
2001-04-02 |
2005-02-25 |
Flamel Tech Sa |
Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
|
MXPA03010672A
(es)
|
2001-05-23 |
2004-03-02 |
Tanabe Seiyaku Co |
Composicion para el tratamiento regenerativo de enfermedades del cartilago.
|
EP1389468A4
(de)
|
2001-05-23 |
2007-01-10 |
Tanabe Seiyaku Co |
Zusammensetzungen zur förderung der knochenfrakturheilung
|
CA2447990C
(en)
*
|
2001-05-31 |
2012-01-31 |
Skyepharma Inc. |
Encapsulation of nanosuspensions in liposomes and microspheres
|
JP2004535431A
(ja)
*
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ, インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
TWI332407B
(en)
*
|
2001-06-29 |
2010-11-01 |
Takeda Chemical Industries Ltd |
Controlled release composition and method of producting the same
|
TWI225416B
(en)
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
CA2452874A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Endo Pharmaceuticals, Inc. |
Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
|
DK1404331T3
(da)
*
|
2001-07-06 |
2008-01-28 |
Penwest Pharmaceuticals Co |
Sustained release-formuleringer af oxymorphon
|
CN1278675C
(zh)
|
2001-07-10 |
2006-10-11 |
佳能株式会社 |
含聚羟基烷醇酸酯的粒状体及其制备方法
|
ES2307779T3
(es)
*
|
2001-08-16 |
2008-12-01 |
Baxter International Inc. |
Formulaciones de microparticulas a base de propelentes.
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
DE60132094T3
(de)
*
|
2001-10-26 |
2012-02-02 |
Octoplus Polyactive Sciences B.V. |
Verfahren zur Herstellung von gereinigten Partikeln
|
WO2003041739A1
(en)
|
2001-11-13 |
2003-05-22 |
Takeda Chemical Industries, Ltd. |
Anticaner agents
|
MXPA04004665A
(es)
|
2001-11-14 |
2004-09-10 |
Alza Corp |
Composiciones de deposito inyectable y uso de los mismos.
|
ES2329346T3
(es)
*
|
2001-11-14 |
2009-11-25 |
Durect Corporation |
Composicion de deposito inyectable.
|
KR20040088519A
(ko)
|
2002-02-22 |
2004-10-16 |
뉴 리버 파마슈티칼스, 인크. |
활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
|
US20070135875A1
(en)
|
2002-04-08 |
2007-06-14 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
US8131371B2
(en)
|
2002-04-08 |
2012-03-06 |
Ardian, Inc. |
Methods and apparatus for monopolar renal neuromodulation
|
US8145316B2
(en)
|
2002-04-08 |
2012-03-27 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
US7162303B2
(en)
|
2002-04-08 |
2007-01-09 |
Ardian, Inc. |
Renal nerve stimulation method and apparatus for treatment of patients
|
US7620451B2
(en)
|
2005-12-29 |
2009-11-17 |
Ardian, Inc. |
Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
|
US8774913B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for intravasculary-induced neuromodulation
|
US8150519B2
(en)
|
2002-04-08 |
2012-04-03 |
Ardian, Inc. |
Methods and apparatus for bilateral renal neuromodulation
|
US7653438B2
(en)
|
2002-04-08 |
2010-01-26 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
US20070129761A1
(en)
|
2002-04-08 |
2007-06-07 |
Ardian, Inc. |
Methods for treating heart arrhythmia
|
US9308044B2
(en)
|
2002-04-08 |
2016-04-12 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
US7756583B2
(en)
|
2002-04-08 |
2010-07-13 |
Ardian, Inc. |
Methods and apparatus for intravascularly-induced neuromodulation
|
US20080213331A1
(en)
|
2002-04-08 |
2008-09-04 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
US9308043B2
(en)
|
2002-04-08 |
2016-04-12 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
US8347891B2
(en)
|
2002-04-08 |
2013-01-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
|
US8145317B2
(en)
|
2002-04-08 |
2012-03-27 |
Ardian, Inc. |
Methods for renal neuromodulation
|
US9636174B2
(en)
|
2002-04-08 |
2017-05-02 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
US7617005B2
(en)
|
2002-04-08 |
2009-11-10 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
US8774922B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
|
US8150520B2
(en)
|
2002-04-08 |
2012-04-03 |
Ardian, Inc. |
Methods for catheter-based renal denervation
|
US20140018880A1
(en)
|
2002-04-08 |
2014-01-16 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
US6978174B2
(en)
|
2002-04-08 |
2005-12-20 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
US7853333B2
(en)
|
2002-04-08 |
2010-12-14 |
Ardian, Inc. |
Methods and apparatus for multi-vessel renal neuromodulation
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
WO2003092468A2
(en)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
FR2840614B1
(fr)
*
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US7166133B2
(en)
*
|
2002-06-13 |
2007-01-23 |
Kensey Nash Corporation |
Devices and methods for treating defects in the tissue of a living being
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
DK1532985T3
(en)
|
2002-06-25 |
2016-12-05 |
Takeda Pharmaceuticals Co |
PROCEDURE FOR PREPARING A COMPOSITION WITH LONG-TERM RELEASE
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
FR2843117B1
(fr)
*
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
CN101057824A
(zh)
|
2002-07-31 |
2007-10-24 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
NZ537955A
(en)
|
2002-07-31 |
2007-10-26 |
Alza Corp |
Injectable depot compositions and uses thereof
|
AU2003261298A1
(en)
*
|
2002-08-02 |
2004-02-23 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
CA2497792C
(en)
*
|
2002-09-06 |
2014-08-05 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
WO2004053056A2
(en)
*
|
2002-09-24 |
2004-06-24 |
University Of Kentucky Research Foundation |
Nanoparticle-based vaccine delivery system containing adjuvant
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
KR100709015B1
(ko)
*
|
2002-11-13 |
2007-04-18 |
(주)아모레퍼시픽 |
지속적 약물방출이 가능한 고분자 미립구 및 그 제조방법
|
EP1562548A1
(de)
*
|
2002-11-14 |
2005-08-17 |
Shear/Kershman Laboratories, Inc. |
Orales testosteron freisetzungsystem mit verzögerter freigabe
|
JP4970731B2
(ja)
*
|
2002-12-04 |
2012-07-11 |
フラメル・テクノロジー |
少なくとも1つの(オリゴ)アミノ酸基によって官能性をもたせたポリアミノ酸およびこれらの適用、特に医療適用
|
JP2006523613A
(ja)
|
2002-12-20 |
2006-10-19 |
エスティ.ジェイムス アソシエイト エルエルシー/フェイバー リサーチ シリーズ |
徐放性医薬投与のための被覆粒子
|
EP3597262B1
(de)
*
|
2002-12-20 |
2023-12-27 |
Xeris Pharmaceuticals, Inc. |
Formulierung für intrakutane injektion
|
WO2004073033A2
(en)
*
|
2003-02-11 |
2004-08-26 |
Venture Management Alliance, Llc |
Material incapsulation system
|
WO2004081196A2
(en)
*
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
JP2006521367A
(ja)
*
|
2003-03-26 |
2006-09-21 |
株式会社Lttバイオファーマ |
ターゲッティングと徐放を目的とした静脈注射用ナノ粒子
|
CA2520660C
(en)
*
|
2003-03-28 |
2013-08-20 |
Sigmoid Biotechnologies Limited |
Solid oral dosage form containing seamless microcapsules
|
JP2004331750A
(ja)
|
2003-05-02 |
2004-11-25 |
Canon Inc |
ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
|
FR2855521B1
(fr)
|
2003-05-28 |
2005-08-05 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
|
US8834864B2
(en)
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
CA2533314C
(en)
|
2003-07-18 |
2013-07-09 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
MXPA06000720A
(es)
*
|
2003-07-18 |
2006-08-23 |
Baxter Int |
Metodos para fabricacion, usos y composiciones de particulas esfericas pequenas preparadas por separacion de fase controlada.
|
EP1646354A4
(de)
*
|
2003-07-22 |
2010-03-17 |
Baxter Int |
Kleine kugelförmige teilchen von niedermolekularen organischen molekülen und herstellungs- und anwendungsverfahren dafür
|
US20090214644A1
(en)
*
|
2003-07-31 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
US20050025825A1
(en)
|
2003-07-31 |
2005-02-03 |
Xanodyne Pharmacal, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
JP2007521231A
(ja)
|
2003-08-08 |
2007-08-02 |
バイオヴェイル ラボラトリーズ インコーポレイテッド |
塩酸ブプロピオンの放出調節錠剤
|
EP1660013A4
(de)
|
2003-08-26 |
2011-07-20 |
Gel Del Technologies Inc |
Protein-biomaterialien und biokoazervate und herstellungs- und verwendungsverfahren dafür
|
FR2860516B1
(fr)
*
|
2003-10-03 |
2006-01-13 |
Flamel Tech Sa |
Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
US20050101605A1
(en)
*
|
2003-11-07 |
2005-05-12 |
Ahmed Salah U. |
Oral liquid formulations of methotrexate
|
FR2862536B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
CA2548822C
(en)
*
|
2003-12-08 |
2015-08-11 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
TW200529890A
(en)
*
|
2004-02-10 |
2005-09-16 |
Takeda Pharmaceutical |
Sustained-release preparations
|
SI1718258T1
(sl)
|
2004-02-23 |
2009-08-31 |
Euro Celtique Sa |
Naprava za transdermalno dajanje opioida, varna pred zlorabo
|
US20050208134A1
(en)
*
|
2004-02-25 |
2005-09-22 |
Shlomo Magdassi |
Biocompatible polymeric beads and use thereof
|
US7947739B2
(en)
|
2004-03-04 |
2011-05-24 |
Ferring B.V. |
Tranexamic acid formulations
|
US20050245614A1
(en)
*
|
2004-03-04 |
2005-11-03 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US20090215898A1
(en)
*
|
2004-03-04 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US8022106B2
(en)
*
|
2004-03-04 |
2011-09-20 |
Ferring B.V. |
Tranexamic acid formulations
|
US20050244495A1
(en)
|
2004-03-04 |
2005-11-03 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
EP1731139A4
(de)
*
|
2004-03-31 |
2008-12-03 |
Aspion Co Ltd |
Pharmazeutische zubereitung vom s/o typ und herstellungsverfahren dafür
|
GB0408308D0
(en)
|
2004-04-14 |
2004-05-19 |
Vectura Ltd |
Pharmaceutical compositions
|
WO2005107714A2
(en)
*
|
2004-05-05 |
2005-11-17 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
AU2005244851B2
(en)
*
|
2004-05-12 |
2010-08-26 |
Baxter Healthcare S.A. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
ES2313350T3
(es)
*
|
2004-05-12 |
2009-03-01 |
Baxter International Inc. |
Microesferas de acido nucleico, produccion y suministro de las mismas.
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
CA2566075A1
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter Healthcare S.A. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
US8461187B2
(en)
*
|
2004-06-16 |
2013-06-11 |
Takeda Pharmaceuticals U.S.A., Inc. |
Multiple PPI dosage form
|
US7740861B2
(en)
*
|
2004-06-16 |
2010-06-22 |
University Of Massachusetts |
Drug delivery product and methods
|
TW200613012A
(en)
*
|
2004-07-02 |
2006-05-01 |
Takeda Pharmaceuticals Co |
Sustained-release composition, process for producing the same and use of the same
|
EP3417895A1
(de)
|
2004-07-28 |
2018-12-26 |
Medtronic Ardian Luxembourg S.à.r.l. |
Verfahren und vorrichtungen für die nierennervenblockade
|
FR2873703B1
(fr)
*
|
2004-07-30 |
2006-12-08 |
Flamel Technologies Sa |
Polyaminoacides branches, fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
FR2873704B1
(fr)
*
|
2004-07-30 |
2006-12-08 |
Flamel Technologies Sa |
Polyaminoacides fonctionnalises par des greffons hydrophobes portant une charge anionique et leurs applications notamment therapeutiques
|
EP1781305A2
(de)
*
|
2004-08-13 |
2007-05-09 |
Angiotech International Ag |
Zusammensetzungen und verfahren mit hyaluronsäure und hyaluronidase-inhibitoren
|
TW200613004A
(en)
*
|
2004-08-31 |
2006-05-01 |
Aspion Co Ltd |
External preparation of solid/oil type
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
WO2006032039A2
(en)
|
2004-09-17 |
2006-03-23 |
University Of Massachusetts |
Compositions and their uses for lysosomal enzyme deficiencies
|
PL1811979T3
(pl)
*
|
2004-09-27 |
2009-04-30 |
Sigmoid Pharma Ltd |
Mikrokapsułki zawierające metyloksantynę i kortykosteroid
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
WO2006041942A2
(en)
*
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
ES2255426B1
(es)
*
|
2004-10-19 |
2007-08-16 |
Gp Pharm, S.A. |
Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
|
JP2008518936A
(ja)
*
|
2004-10-29 |
2008-06-05 |
メディミューン,インコーポレーテッド |
Rsv感染症および関連状態を予防および治療する方法
|
US7937143B2
(en)
|
2004-11-02 |
2011-05-03 |
Ardian, Inc. |
Methods and apparatus for inducing controlled renal neuromodulation
|
EP1824460B1
(de)
*
|
2004-11-10 |
2014-12-24 |
Tolmar Therapeutics, Inc. |
Stabilisiertes polymer-abgabesystem
|
US20080207109A1
(en)
*
|
2005-01-06 |
2008-08-28 |
Oy Halton Group Ltd. |
Ventilation Register and Ventilation Systems
|
FR2881140B1
(fr)
*
|
2005-01-27 |
2007-04-06 |
Flamel Technologies Sa |
Copolyhydroxyalkylglutamines fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
CA2604225A1
(en)
*
|
2005-04-27 |
2006-11-02 |
Baxter International Inc. |
Surface-modified microparticles and methods of forming and using the same
|
US8017152B2
(en)
|
2005-05-27 |
2011-09-13 |
Stratosphere Pharma Ab |
Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
|
EP1726299A3
(de)
*
|
2005-05-27 |
2007-04-18 |
StratoSphere Pharma AB |
Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
|
US8039462B2
(en)
*
|
2005-09-19 |
2011-10-18 |
Neuronascent, Inc. |
Methods and compositons for stimulating neurogenesis and inhibiting neuronal degeneration
|
EP1948245B1
(de)
*
|
2005-10-24 |
2011-10-05 |
University of Massachusetts |
Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
|
FR2892725B1
(fr)
*
|
2005-10-31 |
2011-03-04 |
Flamel Tech Sa |
Acides polyglutamiques fonctionnalises par des derives de l'histidine et des groupements hydrophobes et leurs applications notamment therapeutiques
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
US20080286375A1
(en)
*
|
2005-11-15 |
2008-11-20 |
Amorepacific Corporation |
Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
|
US8546451B2
(en)
*
|
2005-11-28 |
2013-10-01 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US9409856B2
(en)
|
2005-11-28 |
2016-08-09 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US8637706B2
(en)
|
2005-11-28 |
2014-01-28 |
Gtx, Inc. |
Nuclear receptor binding agents
|
JP2009520693A
(ja)
*
|
2005-12-08 |
2009-05-28 |
エムディーアールエヌエー,インコーポレイテッド |
安定化されたエキセンディン製剤の粘膜送達
|
US8916206B2
(en)
*
|
2005-12-26 |
2014-12-23 |
Ltt Bio-Pharma Co., Ltd. |
Nanoparticles containing water-soluble non-peptide low-molecular weight drug
|
CU23388B6
(es)
|
2006-01-31 |
2009-07-16 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
|
KR100722607B1
(ko)
|
2006-05-11 |
2007-05-28 |
주식회사 펩트론 |
분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
|
US9023400B2
(en)
*
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
JP4720620B2
(ja)
*
|
2006-05-30 |
2011-07-13 |
コニカミノルタビジネステクノロジーズ株式会社 |
カール補正装置及びこれを備えた画像形成装置
|
BRPI0712088B8
(pt)
|
2006-05-31 |
2021-06-22 |
Baxter Healthcare Sa |
uso de uma biomatriz de lâmina de colágeno de múltiplas camadas microscópicas não porosa e hermética a fluido
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
TWI436793B
(zh)
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
AU2007281737B2
(en)
*
|
2006-08-04 |
2013-09-19 |
Baxter Healthcare S.A. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
MX2009003661A
(es)
*
|
2006-10-06 |
2009-04-22 |
Baxter Int |
Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
|
JP5196760B2
(ja)
*
|
2006-10-27 |
2013-05-15 |
一般財団法人 九州医療資源財団 |
W/o/w型エマルジョン組成物
|
EP2442107B1
(de)
|
2006-11-01 |
2014-03-12 |
Ventana Medical Systems, Inc. |
Haptene, Haptenkonjugate, Zusammensetzungen daraus und Verfahren für ihre Herstellung und Verwendung
|
US9289196B2
(en)
|
2006-12-12 |
2016-03-22 |
Cook Medical Technologies Llc |
Hemostatic substance with a coating
|
MX2009006653A
(es)
*
|
2006-12-18 |
2009-07-02 |
Takeda Pharmaceutical |
Composicion de liberacion prolongada y metodo para producirla.
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
EP2380564B1
(de)
*
|
2007-04-04 |
2014-10-22 |
Sigmoid Pharma Limited |
Orale pharmazeutische Zusammensetzung
|
EP2061587A1
(de)
|
2007-04-26 |
2009-05-27 |
Sigmoid Pharma Limited |
Herstellung mehrerer minikapseln
|
US20100215737A1
(en)
*
|
2007-05-01 |
2010-08-26 |
Ivan Coulter |
Combination pharmaceutical compositions
|
FR2915748B1
(fr)
|
2007-05-03 |
2012-10-19 |
Flamel Tech Sa |
Acides polyglutamiques fonctionnalises par des groupes cationiques et des groupements hydrophobes et leurs applications, notamment therapeutiques
|
EP2156848A4
(de)
*
|
2007-05-14 |
2012-11-28 |
Ltt Bio Pharma Co Ltd |
Niedermolekulares arzneimittelhaltiges nanoteilchen mit negativ geladener gruppe mit verzögerter freisetzung
|
EP1997830A1
(de)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
|
US20080318994A1
(en)
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
|
ES2564826T3
(es)
*
|
2007-06-21 |
2016-03-29 |
Neuronascent, Inc. |
Métodos y composiciones para estimular neurogénesis e inhibir degeneración neuronal utilizando isotiazolopirimidinonas
|
US20080318993A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
|
US9040468B2
(en)
|
2007-07-25 |
2015-05-26 |
Schlumberger Technology Corporation |
Hydrolyzable particle compositions, treatment fluids and methods
|
US10011763B2
(en)
|
2007-07-25 |
2018-07-03 |
Schlumberger Technology Corporation |
Methods to deliver fluids on a well site with variable solids concentration from solid slurries
|
JP4526598B2
(ja)
*
|
2007-08-29 |
2010-08-18 |
祐徳薬品工業株式会社 |
乳化型外用剤およびその製造方法
|
CN104069088A
(zh)
*
|
2007-10-12 |
2014-10-01 |
武田制药北美公司 |
与食物摄入无关的治疗胃肠病症的方法
|
EP2222283A2
(de)
*
|
2007-10-29 |
2010-09-01 |
University of Massachusetts |
Zur freisetzung von nukleinsäuren (sirna) mit hefe-zellwandproteinen verkapselte mehrlagige nanopatikel
|
JP2011500237A
(ja)
|
2007-10-30 |
2011-01-06 |
バクスター・インターナショナル・インコーポレイテッド |
内臓または体腔壁の欠陥を治療するための再生性の生体機能性コラーゲン生物基質の使用
|
EP2219775A4
(de)
*
|
2007-12-11 |
2012-10-03 |
Univ Nanyang Tech |
Mehrschichtige hohle mikrokügelchen für die freisetzung hydrophiler wirkstoffe
|
AU2008345047A1
(en)
*
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Biocompatible protein particles, particle devices and methods thereof
|
WO2009086270A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Khashayar Kevin Neshat |
Controlled release local anesthetic for post dental surgery and method of use
|
US20090202642A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Xiao Huang |
Drug Delivery System Comprising Microparticles and Gelation System
|
GB2469965B
(en)
*
|
2008-02-18 |
2012-06-20 |
Csir |
Nanoparticle carriers for drug administration and process for producing same
|
RU2545810C2
(ru)
|
2008-02-29 |
2015-04-10 |
Ферросан Медикал Дивайсиз А/С |
Устройство для ускорения остановки кровотечения и/или заживления ран
|
KR100963435B1
(ko)
*
|
2008-06-19 |
2010-06-17 |
한국과학기술연구원 |
서방형 약물전달 및 조직재생용 덮인 다공성 생분해성고분자 미립구의 제조 방법
|
EP2315571A4
(de)
*
|
2008-07-16 |
2013-05-01 |
Surmodics Pharmaceuticals Inc |
Verfahren zur herstellung von mikropartikeln mit bioaktiven peptiden
|
US8815818B2
(en)
|
2008-07-18 |
2014-08-26 |
Rxi Pharmaceuticals Corporation |
Phagocytic cell delivery of RNAI
|
US8034382B2
(en)
*
|
2008-07-31 |
2011-10-11 |
The Board Of Trustees Of The University Of Arkansas |
Preparation method for biodegradable micro-particles containing drugs
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20100062057A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Pronova BioPharma Norge AS. |
Formulation
|
US8796443B2
(en)
|
2008-09-22 |
2014-08-05 |
Rxi Pharmaceuticals Corporation |
Reduced size self-delivering RNAi compounds
|
US8741259B2
(en)
|
2008-10-20 |
2014-06-03 |
Marvin C. Gershengorn |
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
|
WO2010048302A1
(en)
|
2008-10-21 |
2010-04-29 |
Oregon Health & Science University |
Naphthamides as anticancer agents
|
WO2010057177A2
(en)
|
2008-11-17 |
2010-05-20 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US8652129B2
(en)
|
2008-12-31 |
2014-02-18 |
Medtronic Ardian Luxembourg S.A.R.L. |
Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
|
US9493774B2
(en)
|
2009-01-05 |
2016-11-15 |
Rxi Pharmaceuticals Corporation |
Inhibition of PCSK9 through RNAi
|
WO2010085607A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Surmodics Pharmaceuticals, Inc. |
Continuous double emulsion process for making microparticles
|
WO2010090762A1
(en)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
US9427418B2
(en)
|
2009-02-23 |
2016-08-30 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US9624161B2
(en)
|
2009-02-23 |
2017-04-18 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
AU2010222648B2
(en)
|
2009-03-09 |
2016-07-07 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
EP2424488B1
(de)
*
|
2009-04-27 |
2023-06-07 |
Premier Dental Products Company |
Mikroverkapselte zusammensetzungen und verfahren für gewebemineralisierung
|
US20100280117A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Xanodyne Pharmaceuticals, Inc. |
Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
|
GB2483815B
(en)
|
2009-05-18 |
2013-12-25 |
Sigmoid Pharma Ltd |
Composition comprising oil drops
|
US9039783B2
(en)
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
EP2442835B1
(de)
|
2009-06-16 |
2014-12-10 |
Baxter International Inc |
Blutstillender schwamm
|
EP2464341B1
(de)
|
2009-08-12 |
2022-07-06 |
Sublimity Therapeutics Limited |
Immunmodulatorische zusammensetzungen mit einer polymermatrix und einer ölphase
|
GB0915480D0
(en)
*
|
2009-09-04 |
2009-10-07 |
Arecor Ltd |
Stable formulation of factor viii
|
AU2010295646B2
(en)
|
2009-09-15 |
2016-02-11 |
Ellipses Pharma Limited |
Treatment of cancer
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
ES2363965B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm S.A. |
Cápsulas de principios activos betabloqueantes y ésteres de ácidos grasos poliinsaturados.
|
ES2363964B1
(es)
|
2009-11-20 |
2012-08-22 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
|
ES2364011B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
|
AU2010321533A1
(en)
*
|
2009-11-23 |
2012-05-31 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
JP2013514093A
(ja)
|
2009-12-16 |
2013-04-25 |
バクスター・インターナショナル・インコーポレイテッド |
止血スポンジ
|
US20130236551A1
(en)
|
2009-12-23 |
2013-09-12 |
Defiante Farmaceutica .S.A. |
Combination composition useful for treating cardiovascular diseases
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
EP2353588B1
(de)
*
|
2010-01-21 |
2015-04-15 |
Agricultural Technology Research Institute |
Präparat mit verzögerter Freisetzung von Faktor IX
|
WO2011094426A1
(en)
|
2010-01-29 |
2011-08-04 |
The United State Of America, As Represented By The Secretary, Department Of Health & Human Services |
Caspase inhibitors
|
US9205577B2
(en)
*
|
2010-02-05 |
2015-12-08 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
US9138309B2
(en)
|
2010-02-05 |
2015-09-22 |
Allergan, Inc. |
Porous materials, methods of making and uses
|
CA2792523C
(en)
*
|
2010-03-09 |
2018-01-09 |
Alkermes Pharma Ireland Limited |
Alcohol resistant enteric pharmaceutical compositions
|
ES2626151T3
(es)
|
2010-03-12 |
2017-07-24 |
Monsanto Technology Llc |
Composiciones agroquímicas en gel
|
CN101816910B
(zh)
*
|
2010-03-25 |
2011-12-07 |
陕西师范大学 |
固载十六烷基三甲基磷钨酸季铵盐杂化微凝胶的制备方法
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
AU2011237421B2
(en)
|
2010-04-08 |
2016-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inverse agonists and neutral antagonists for the TSH receptor
|
US11202853B2
(en)
*
|
2010-05-11 |
2021-12-21 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
EP2571525A4
(de)
|
2010-05-18 |
2016-04-27 |
Cerulean Pharma Inc |
Zusammensetzungen und verfahren zur behandlung von autoimmun- und anderen erkrankungen
|
CN103037847B
(zh)
|
2010-06-01 |
2016-01-20 |
巴克斯特国际公司 |
用于制备干燥、稳定的止血组合物的方法
|
CN103037845B
(zh)
|
2010-06-01 |
2015-11-25 |
巴克斯特国际公司 |
用于制备干燥、稳定的止血组合物的方法
|
CN102917691A
(zh)
|
2010-06-01 |
2013-02-06 |
巴克斯特国际公司 |
用于生产干燥、稳定的止血组合物的方法
|
ES2385240B1
(es)
|
2010-07-26 |
2013-09-23 |
Gp-Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
|
WO2012024229A1
(en)
|
2010-08-14 |
2012-02-23 |
University Of Massachusetts |
Yeast cell wall particle for receptor-targeted nanoparticle delivery
|
GB201016433D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Apparatus and method for making solid beads
|
GB201016436D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Method of making solid beads
|
US9132291B2
(en)
|
2010-10-05 |
2015-09-15 |
Dfb Technology, Ltd. |
Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
|
US9066720B2
(en)
|
2010-10-25 |
2015-06-30 |
Medtronic Ardian Luxembourg S.A.R.L. |
Devices, systems and methods for evaluation and feedback of neuromodulation treatment
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US10821085B2
(en)
|
2010-12-07 |
2020-11-03 |
Kimberly-Clark Worldwide, Inc. |
Wipe coated with a botanical composition having antimicrobial properties
|
US9832993B2
(en)
|
2010-12-07 |
2017-12-05 |
Kimberly-Clark Worldwide, Inc. |
Melt processed antimicrobial composition
|
US8445032B2
(en)
|
2010-12-07 |
2013-05-21 |
Kimberly-Clark Worldwide, Inc. |
Melt-blended protein composition
|
US9648874B2
(en)
|
2010-12-07 |
2017-05-16 |
Kimberly-Clark Worldwide, Inc. |
Natural, multiple use and re-use, user saturated wipes
|
US8524264B2
(en)
|
2010-12-07 |
2013-09-03 |
Kimberly-Clark Worldwide, Inc. |
Protein stabilized antimicrobial composition formed by melt processing
|
US9149045B2
(en)
|
2010-12-07 |
2015-10-06 |
Kimberly-Clark Worldwide, Inc. |
Wipe coated with a botanical emulsion having antimicrobial properties
|
WO2012125486A1
(en)
|
2011-03-11 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination chemotherapy for treating cancer
|
WO2012125787A1
(en)
|
2011-03-17 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFβ AND RUNX1 PROTEINS
|
WO2013039792A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunogens based on an hiv-1 gp120 v1v2 epitope
|
WO2013049535A2
(en)
|
2011-09-30 |
2013-04-04 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Influenza vaccine
|
JP6195569B2
(ja)
|
2011-10-11 |
2017-09-13 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
止血組成物
|
CN103957948B
(zh)
|
2011-10-11 |
2016-10-26 |
巴克斯特国际公司 |
止血组合物
|
US9149528B2
(en)
|
2011-10-13 |
2015-10-06 |
Premier Dental Products Company |
Topical vitamin D oral supplement compositions
|
SA112330957B1
(ar)
|
2011-10-27 |
2015-08-09 |
باكستر انترناشونال انك. |
تركيبات لإيقاف النزف
|
WO2013072767A1
(en)
|
2011-11-18 |
2013-05-23 |
Pronova Biopharma Norge As |
Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
|
US8574628B2
(en)
|
2011-12-19 |
2013-11-05 |
Kimberly-Clark Worldwide, Inc. |
Natural, multiple release and re-use compositions
|
WO2013106847A1
(en)
|
2012-01-13 |
2013-07-18 |
Oregon Health & Science University |
Compounds, compositions and associated methods comprising 3-aryl quinolines
|
JP6241624B2
(ja)
|
2012-03-06 |
2017-12-06 |
フェロサン メディカル デバイシーズ エイ/エス |
止血ペーストを収容する加圧容器
|
EP3348220A1
(de)
|
2012-03-08 |
2018-07-18 |
Medtronic Ardian Luxembourg S.à.r.l. |
Biomarkerprobenahme in zusammenhang mit neuromodulationsvorrichtungen sowie entsprechende systeme
|
US9750568B2
(en)
|
2012-03-08 |
2017-09-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Ovarian neuromodulation and associated systems and methods
|
US8979991B2
(en)
|
2012-03-21 |
2015-03-17 |
Loma Linda University |
Substances and method for replacing natural tooth material
|
WO2013150384A1
(en)
|
2012-04-04 |
2013-10-10 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin d for psoriasis, and methods and uses thereof
|
ES2606392T3
(es)
|
2012-04-04 |
2017-03-23 |
Pronova Biopharma Norge As |
Composiciones que comprenden ácidos grasos omega-3 y vitamina D para acné vulgar y/o eccema, y procedimientos y usos de las mismas
|
ES2734567T3
(es)
|
2012-06-08 |
2019-12-10 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Inhibidores de FBXO3
|
CA2874290C
(en)
|
2012-06-12 |
2020-02-25 |
Ferrosan Medical Devices A/S |
Dry haemostatic composition
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
US9724542B2
(en)
|
2012-10-12 |
2017-08-08 |
Premier Dental Products Company |
Remineralizing and desensitizing compositions, treatments and methods of manufacture
|
US9877930B2
(en)
|
2012-10-12 |
2018-01-30 |
Premier Dental Products Company |
Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
|
US20140110296A1
(en)
|
2012-10-19 |
2014-04-24 |
Medtronic Ardian Luxembourg S.A.R.L. |
Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
|
US9765031B2
(en)
|
2012-11-13 |
2017-09-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor mediating compounds
|
US20140142522A1
(en)
*
|
2012-11-16 |
2014-05-22 |
NU Technology, LLC |
Moist dressing with honeycomb pattern and drain channels
|
WO2014093702A1
(en)
|
2012-12-12 |
2014-06-19 |
The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Hiv therapeutics and methods of making and using same
|
EP2961384B1
(de)
|
2013-02-28 |
2019-08-28 |
Basf As |
Zusammensetzung mit einer lipidverbindung, einem triglycerid und einem tensid sowie verfahren zur verwendung davon
|
KR101486132B1
(ko)
|
2013-03-20 |
2015-01-23 |
씨제이헬스케어 주식회사 |
졸-겔 변환 특성을 갖는 고분자를 이용한 미립구의 제조방법 및 이로부터 제조된 미립구
|
CA2907765C
(en)
|
2013-03-21 |
2021-07-06 |
Eupraxia Pharmaceuticals USA LLC |
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
|
KR101543507B1
(ko)
|
2013-05-15 |
2015-08-11 |
씨제이헬스케어 주식회사 |
연속 공정의 미립구의 제조 방법 및 이로부터 제조된 미립구
|
CA2912064A1
(en)
|
2013-05-16 |
2014-11-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for inhibiting drug-resistant strains of hiv-1 integrase
|
CA2912357C
(en)
|
2013-06-21 |
2019-12-31 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
BR112016002342A8
(pt)
|
2013-08-06 |
2018-01-23 |
Dong Kook Pharm Co Ltd |
microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica
|
CN103432093B
(zh)
*
|
2013-08-31 |
2015-03-25 |
西南大学 |
甲磺酸普立地诺骨架缓释片及其制备方法
|
EP3046561B1
(de)
|
2013-09-20 |
2023-02-22 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Verbindungen zur behandlung von prostatakrebs
|
CA2926950C
(en)
|
2013-10-10 |
2022-10-11 |
Eastern Virginia Medical School |
4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
AU2014361291B2
(en)
|
2013-12-11 |
2017-11-30 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
WO2015106003A1
(en)
|
2014-01-08 |
2015-07-16 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Ras pathways as markers of protection against hiv and methods to improve vaccine efficacy
|
US10194979B1
(en)
|
2014-03-28 |
2019-02-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for catheter-based renal neuromodulation
|
US10194980B1
(en)
|
2014-03-28 |
2019-02-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for catheter-based renal neuromodulation
|
US9980766B1
(en)
|
2014-03-28 |
2018-05-29 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and systems for renal neuromodulation
|
HUE052289T2
(hu)
|
2014-03-31 |
2021-04-28 |
Pharmathen Sa |
Peptiddel töltött, szabályozott hatóanyagleadási tulajdonságokkal rendelkezõ PLGA mikrogyöngyök elõállítása
|
CN106660968B
(zh)
|
2014-05-09 |
2020-02-07 |
美国政府(由卫生和人类服务部的部长所代表) |
吡唑衍生物及其作为大麻素受体介体的用途
|
WO2016033100A1
(en)
|
2014-08-25 |
2016-03-03 |
Salk Institute For Biological Studies |
Novel ulk1 inhibitors and methods using same
|
EP3189067B1
(de)
|
2014-09-04 |
2021-05-19 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Rekombinante hiv-1 hüllproteine und deren verwendung
|
CN106999621B
(zh)
|
2014-10-13 |
2020-07-03 |
弗罗桑医疗设备公司 |
用于止血和伤口愈合的干组合物
|
US20160106804A1
(en)
*
|
2014-10-15 |
2016-04-21 |
Yuhua Li |
Pharmaceutical composition with improved stability
|
WO2016064716A1
(en)
|
2014-10-20 |
2016-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination therapy of tshr antagonist and igfr inhibitor
|
PT3215127T
(pt)
|
2014-11-07 |
2021-02-10 |
Sublimity Therapeutics Ltd |
Composições que compreendem ciclosporina
|
AU2015371184B2
(en)
|
2014-12-24 |
2020-06-25 |
Ferrosan Medical Devices A/S |
Syringe for retaining and mixing first and second substances
|
US10420834B2
(en)
|
2014-12-24 |
2019-09-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus F proteins and their use
|
WO2016112036A1
(en)
|
2015-01-05 |
2016-07-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Myc g-quadruplex stabilizing small molecules and their use
|
PE20180021A1
(es)
|
2015-02-20 |
2018-01-09 |
Univ Oregon Health & Science |
Derivados de sobetiroma
|
US10017471B2
(en)
|
2015-04-21 |
2018-07-10 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10806720B2
(en)
|
2015-04-21 |
2020-10-20 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US9834507B2
(en)
|
2015-04-21 |
2017-12-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10865184B2
(en)
|
2015-04-21 |
2020-12-15 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10441570B2
(en)
|
2015-04-21 |
2019-10-15 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) Ligands and methods of use thereof
|
EP3286164A4
(de)
|
2015-04-21 |
2018-12-05 |
Gtx, Inc. |
Selektive liganden des androgenrezeptordegraders (sard) und verfahren zur verwendung davon
|
MX2017013565A
(es)
|
2015-04-21 |
2018-02-19 |
Gtx Inc |
Ligandos degradadores selectivos del receptor androgénico (sard) y sus métodos uso.
|
US10654809B2
(en)
|
2016-06-10 |
2020-05-19 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10093613B2
(en)
|
2015-04-21 |
2018-10-09 |
Gtx, Inc. |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10035763B2
(en)
|
2015-04-21 |
2018-07-31 |
Gtx, Inc. |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
BR112017023164A2
(pt)
|
2015-04-28 |
2018-07-24 |
Pronova Biopharma Norge As |
composto, e, método de prevenir e/ou tratar a esteato-hepatite não alcoólica em um indivíduo em necessidade do mesmo
|
US20180273485A1
(en)
|
2015-06-04 |
2018-09-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Cannabinoid receptor mediating compounds
|
WO2017005590A1
(en)
|
2015-07-03 |
2017-01-12 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
US10799580B2
(en)
|
2015-09-09 |
2020-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Expression vector delivery system and use thereof for inducing an immune response
|
CA3003159A1
(en)
|
2015-10-27 |
2017-05-04 |
Eupraxia Pharmaceuticals Inc. |
Sustained release formulations of local anesthetics
|
US11464748B2
(en)
|
2016-02-01 |
2022-10-11 |
Emory University |
Particles for targeted delivery and uses in managing bleeding or blood clotting
|
WO2017151802A1
(en)
|
2016-03-04 |
2017-09-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor mediating compounds
|
DK3457851T3
(da)
|
2016-05-18 |
2021-09-20 |
Univ Oregon Health & Science |
Derivater af sobetirom
|
US10806719B2
(en)
|
2016-06-10 |
2020-10-20 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US11230523B2
(en)
|
2016-06-10 |
2022-01-25 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
MX2018015179A
(es)
|
2016-06-10 |
2019-10-14 |
Univ Tennessee Res Found |
Ligandos degradadores selectivos del receptor de androgenos (sard) y metodos de uso de los mismos.
|
WO2017218963A1
(en)
|
2016-06-16 |
2017-12-21 |
Acies Bio D.O.O. |
Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity
|
MX2019006349A
(es)
|
2016-12-16 |
2019-08-22 |
Inst Res Biomedicine |
Proteinas recombinantes rsv f de prefusion nuevas y usos de las mismas.
|
US9962342B1
(en)
*
|
2017-03-14 |
2018-05-08 |
Sunny Pharmtech Inc. |
Pharmaceutical composition containing guaifenesin and application thereof
|
JOP20200068A1
(ar)
|
2017-09-26 |
2020-04-27 |
Nanomi B V |
طريقة لتحضير جسيمات دقيقة بواسطة تقنية مستحلب مزدوج
|
WO2019099595A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
NANO-EMULSION OF CBFβ-RUNX1 INHIBITOR FOR OCULAR DRUG DELIVERY
|
IL275002B2
(en)
|
2017-12-06 |
2024-04-01 |
Basf As |
Fatty acid antecedents for the treatment of nonalcoholic fatty liver disease
|
WO2019118803A1
(en)
|
2017-12-14 |
2019-06-20 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Services |
Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
|
CN110123634A
(zh)
|
2018-02-09 |
2019-08-16 |
株式会社理光 |
颗粒的制造方法,颗粒的制造装置,以及颗粒
|
SG11202008536QA
(en)
|
2018-03-29 |
2020-10-29 |
Elex Biotech Inc |
Compounds for treatment of cardiac arrhythmias and heart failure
|
EP3790600B1
(de)
|
2018-05-09 |
2023-12-27 |
Ferrosan Medical Devices A/S |
Verfahren zur herstellung einer hämostatischen zusammensetzung
|
CN113164435A
(zh)
|
2018-05-16 |
2021-07-23 |
田纳西大学研究基金会 |
选择性雄激素受体降解剂(sard)配体和其使用方法
|
FR3082842A1
(fr)
|
2018-06-21 |
2019-12-27 |
Veru Inc. |
Polymorphe de cis-clomiphene (zuclomiphene) et procedes d'utilisation de celui-ci
|
EP3856754A1
(de)
|
2018-09-25 |
2021-08-04 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
2'-halogenierte-4'-thio-2'-deoxy-5-azacytidin-analoga und deren verwendung
|
AU2019397067A1
(en)
|
2018-12-12 |
2021-07-22 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
CN113784950A
(zh)
|
2019-03-01 |
2021-12-10 |
速通医疗公司 |
新型拟甲状腺素药
|
EP3937917B1
(de)
|
2019-03-11 |
2023-11-15 |
Oregon State University |
Analoga und derivate von cephalotaxin und verfahren zur herstellung und verwendung der verbindungen
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|
EP4192509A1
(de)
|
2020-08-05 |
2023-06-14 |
Ellipses Pharma Ltd |
Behandlung von krebs mit einem cyclodextrinhaltigen polymer-topoisomerase-inhibitor-konjugat und einem parp-inhibitor
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
EP4352054A1
(de)
|
2021-06-09 |
2024-04-17 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Verbindungen zur bindung nichtkanonischer g-quadruplex-strukturen und verfahren zur herstellung und verwendung davon
|
WO2023056368A1
(en)
|
2021-09-30 |
2023-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
|
WO2023059867A1
(en)
|
2021-10-08 |
2023-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for treating or preventing alzheimer's disease
|
WO2023146771A1
(en)
|
2022-01-25 |
2023-08-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gingerenone a prodrugs as senotherapeutics and methods of use
|
WO2023172751A1
(en)
|
2022-03-10 |
2023-09-14 |
University Of Massachusetts |
Devices and methods of treating wounds
|
WO2023177568A1
(en)
|
2022-03-14 |
2023-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor modulating compounds
|